Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 12.99
+0.34 (2.69%)
At close: Mar 27, 2025, 2:57 PM CST
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.26B CNY in the quarter ending September 30, 2024, with 8.31% growth. This brings the company's revenue in the last twelve months to 5.70B, up 27.69% year-over-year. In the year 2023, Yili Chuanning Biotechnology had annual revenue of 4.82B with 26.24% growth.
Revenue (ttm)
5.70B
Revenue Growth
+27.69%
P/S Ratio
5.03
Revenue / Employee
1.98M
Employees
2,881
Market Cap
28.17B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |